California Digitek Lawyers Class Action Recall Attorneys Serving Southern and Northern California in Los Angeles, San Francisco, Orange County, San Diego, Sacramento, San Jose Digitalis Heart Attack Lawyer, Side Effect Wrongful Death Attorney Reviewing Digitek Induced Toxicity Including in Patients with Renal Failure or Who are on Dialysis.

Our California Digitek pharmaceutical product liability lawyers are pleased to provide free case evaluations to persons who have suffered side effects or adverse reactions to Digitek tablets. The manufacturer of Digitek, Actavis Totowa LLC, issued a nationwide Class 1 recall of all strengths of Digitek tablets on April 25, 2008. The Class 1 recall was issued on the basis that the product poses a substantial risk of serious injury or death.The Digitek tablets were distributed by UDL Laboratories, under a UDL label and by Mylan Pharmaceuticals, with a “Bertek” label.

Digitek is the Actavis brand name for Digoxin tablets, commonly prescribed as treatment for abnormal heart rhythms and heart failure. The manufacturer issued the Class 1 national recall because Digitek tablets were distributed to pharmacies with double the thickness and it is presumed, twice the indicated dosage of the active ingredient. The Food and Drug administration has received adverse reaction reports of illness and injury resulting from ingestion of Digitek tablets, and many others have come forward across the nation with symptoms typical of digitalis toxicity. Our pharmaceutical product liability lawyers have arrived at the conclusion that the double strength Digitek tablets pose the serious risk of toxicity, including the risk of death, particularly in patients with renal failure and those who are on dialysis.

If you have suffered a heart attack or other side effect of the drug, or if a loved one has passed away as the result of an adverse reaction to the drug, you are welcome to contact our Digitek lawyers. Simply fill out the free Digitek attorney consultation request, at the top right of this page, and one of our highly qualified Henke Law Group pharmaceutical product liability attorneys will call you to discuss your case and provide you with our case evaluation.

Our Digitek lawyers will consider cases involving serious toxicity, illness or injury resulting from an adverse reaction from Digitek overdose, and in particular, toxic reactions to Digitek in patients who suffer renal failure or who were on dialysis at the time they ingested the Digitek tablets. It appears from the notice of Class 1 recall that the Digitek manufacturer has acknowledged the manufacturing defect, specifically the inclusion of twice the indicated dosage of the drug, which is also, in our opinion, persuasive evidence of manufacturer negligence.

The high dosages of Digitek can result in Digitalis toxicity, which can lead to low blood pressure, cardiac instability, bradycardia, meaning a slow heartbeat, and death, often presenting also with nausea, vomiting, and dizziness.

Digitek Class Action Attorneys and Lawyers for Individually Prosecuted Cases.

Some lawyers are class action lawyers, always joining all their cases in class actions. Other lawyers are capable of trying pharmaceutical product liability cases, and will be more likely to objectively evaluate what is in the best interest of the client and recommend that the client either avail the option of pursuing a case by class action or by trying the litigation as an individual case. Among our many credentials as pharmaceutical product liability lawyers, discussed briefly in the right column of this page, attorney Ray Henke made the federal appellate law which permits the individual client in pharmaceutical product liability cases to decide whether he wishes to pursue his litigation in the context of a class action or pursue his litigation individually. The name of the published decision from the United States Court of Appeals for the Sixth Circuit is In re. Bendectin. The Plaintiffs lead counsel committee in that case had sought to create a "mandatory class action" that would bind 1000 serious birth defect cases pending in the Southern District of Ohio as well as all others of the thousands of Bendecting birth defect cases pending in federal or state courts nationwide, without the consent or agreement of the individual clients or their attorneys. The federal district court judge agreed with the Plaintffs lead counsel committee and certified the mandatory class action. Then the Plaintiffs lead counsel committee and the attorneys for the defendant, Merrill Dow Pharmaceuticals, entered into a $120,000,000 settlement of all cases. That settlement would have resulted in multimillion dollar windfalls for the attorneys but merely a few thousand dollars for the many thousands of individual birth injured children. Henke filed a petition for writ of mandamus in the federal court of appeals, asking the federal appellate court to overturn the district court's order certifying the mandatory class action and for an order voiding the class settlement. The Court of Appeals for the Sixth Circuit issued a published opinion adopting Henke's arguments, holding that except in the case of a limited fund insufficient to pay the damages of all plaintiffs, that mandatory class action unreasonably imposes on the right of the individual plaintiff to his choice of the attorney to represent him and control over his individual litigation. On Henke's petition for writ of mandamus, the United States Court of Appeals overturned the district court's certification of the mandatory class action and threw out the settlement purporting to bind all plaintiffs nationwide, and issued a published opinion strictly limiting from that day forward the availability of mandatory class action, as opposed to voluntary class action.

Class actions can be useful in many types of litigation and for many plaintiffs, depending on the facts of their cases. Since our pharmaceutical product liability lawyers have participated on Plaintiffs lead counsel committees in pharmaceutical class actions, and also have a track record of trying these cases independently, we make the decisions to avail class actions on the basis of our evaluation of the qualities of the class action and the case by case interests of our individual clients. We consider that we can thus provide superior advice and representation for our clients injured as the result of drug product defects.

Again, our Digitek lawyers are pleased to provide free attorney consultations. Simply fill out the case evaluation request at the upper right of this page and one of our Digitek side effect attorneys will contact you to inquire with regard to your history of ingestion of Digitek, your resulting symptoms and illness or injury and we will provide you with our free case consultation.